Navigation Links
Plant microbe shares features with drug-resistant pathogen
Date:6/16/2009

UPTON, NY -- An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. The findings suggest caution in the use of the plant-associated strain for a range of biotech applications. The genetic analysis was conducted in part at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, and will be published in the July 2009 issue of Nature Reviews Microbiology, now available online.

The research team - which included scientists from Ireland, Austria, and the United Kingdom as well as the U.S. - was investigating the versatility and adaptability of a group of bacteria known as Stenotrophomonas. These bacteria have great metabolic versatility, allowing them to thrive in very diverse environments.

The scientists were particularly interested in comparing two strains of S. maltophilia whose genomes were recently decoded to see why these strains - one isolated as an opportunistic pathogen from a clinical setting (strain K279a), and the other from the roots of poplar trees (strain R551-3) - were so well-suited to their very different environments. Such comparisons are made possible by the high throughput and cost-effective DNA sequencing capacity developed by DOE's Joint Genome Institute, as well as the Sanger Institute, to help elucidate the role of microorganisms in health, energy, and environmental processes.

"Surprisingly, we observed very few differences between the opportunistic pathogen and the common plant bacterium," said Brookhaven Lab microbiologist Daniel (Niels) van der Lelie, an expert on soil- and plant-associated microbes, whose team provided the data on the plant-dwelling strain.

For one thing, the scientists found genes that make the bacteria resistant to a wide range of antibiotics in both strains. "This suggests that antibiotic resistance is pa
'/>"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Protein that triggers plant cell division revealed by researchers
2. Is this the beginning of the end of plant breeding?
3. REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
4. NASA satellite detects red glow to map global ocean plant health
5. Scientists develop a new HIV microbicide -- and a way to mass produce it in plants
6. Understanding plants overactive immune system will help MU researchers build better crops
7. MSU discoveries upend traditional thinking about how plants make certain compounds
8. Plant Min protein sits tight and rescues E. coli
9. ISU researcher identifies genetic pathway responsible for much of plant growth
10. MIT’s implantable device offers continuous cancer monitoring
11. Bacteria create aquatic superbugs in waste treatment plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)... , March 23, 2015 SoundView Technology Group ... NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was one ... feedback on their experience with the Wocket in multiple scenarios ... CVS, Whole Foods and other retailers, making both debit and ... Tuttle also says, "If the company meets their plans ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... have published a step by step plan to one-day end ... developing plants that produce their own fertilizer. , ... required to produce nitrogen fertilizers has pushed the world-wide cost ... says that while they are necessary for high yields, those ...
... LOVE YOU! A red splash on a toxic butterfly,s wing ... mimic the wing pattern of another toxic species in the area. ... DON,T EAT US! , Now several research teams that ... butterflies mimic each other,s red wing patterns through changes in the ...
... Irvine, Calif., July 21, 2011 For 150 years ... the best-known examples of this is how poisonous butterflies from ... in effect joining forces to warn predators, "Don,t eat us," ... international team of researchers led by Robert Reed, UC Irvine ...
Cached Biology News:An eye gene colors butterfly wings red 2UCI-led butterfly study sheds light on convergent evolution 2
(Date:4/20/2015)... , April 20, 2015  Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal and metabolic diseases, today ... has joined the Company,s Board of Directors. Dr. ... board level experience, having built and led teams ... regulatory approval and into healthcare systems globally. ...
(Date:4/20/2015)... 20, 2015  Eli Lilly and Company (NYSE: ... targeted cancer therapies, reflecting Lilly,s diverse oncology pipeline, during ... 2015, held April 18-22 in Philadelphia ... Patients" is the theme of this year,s AACR meeting ... broadening its portfolio of therapies that accelerate the pace ...
(Date:4/20/2015)... DELHI , April 20, 2015 ... PI3K Targeting Supramolecular Therapeutic Using the VOLVOX Platform - ... EST  -  Supramolecular Assembly of Antibody-drug ... Cytotoxic Payload - Presented on Sunday, Apr 19, 1:00 ... leader in supramolecular therapeutic program, today announced that the ...
(Date:4/20/2015)... BEIJING, April 20, 2015 Sinovac Biotech Ltd. ... China, today announced its unaudited financial results for the ... Fourth Quarter 2014 Financial Highlights(Compared to the ... $20.3 million, a decrease of 11.4% from $22.9 million ... the stockpiling of H5N1 pandemic influenza vaccine of $0.1 ...
Breaking Biology Technology:Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 2Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 6Invictus Oncology Announces Two Posters to be Presented Describing its Platform Technology on Supramolecular Therapeutics at the American Association for Cancer Research Annual Meeting, 2015 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18
... Insmed Inc. (Nasdaq CM: INSM ... host a conference call on Wednesday, May 13th at ... the first quarter 2009. Insmed intends to issue ... opens on May 13th.To participate in the live conference ...
... - Fourth Quarter 2008 Revenue Increased 28.6% to $14.1 Million, with Net, ... - 2008 Revenues Increased 23.5% to $59.1 Million vs. 2007, ... 20.1%, - 2008 Net Income Increased 13.7% to $4.1 Million ... - 2008 Cash Flow from Operations was $5.9 million, , ...
... Akaza Research will be conducting a presentation and exhibiting OpenClinica at ... Colorado Convention Center in Denver, CO. , ... Denver, ... Exhibition of the Association of Clinical Research Professionals (ACRP) will include ...
Cached Biology Technology:Insmed to Host First Quarter 2009 Conference Call 2China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 2China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 3China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 4China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 5China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 6China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 7China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 8China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 9China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 10China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 11Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition 2
... system, 220-240 V, is used for biolistic particle ... employs an adjustable helium pulse to sweep DNA-, ... inner wall of a small plastic cartridge directly ... for in situ, in vitro, in vivo, and ...
... Hybridization Wash Pack provides optimized blocking ... Preparation Quality Clarifier: Ready-to-use wash solutions ... SigmaScreen(tm) APS Coated Slides for Microarrays ... Hybridization Blocking Buffer: 1L • Microarray ...
Mouse polyclonal antibody raised against a partial recombinant MHC2TA. NCBI Entrez Gene ID = 4261...
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL...
Biology Products: